Related Experiment Video
Updated: Sep 3, 2025

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
11.6K
Gray Matter Abnormalities in Myotonic Dystrophy Type 1: A Voxel-Wise Meta-Analysis
Qirui Jiang1, Junyu Lin1, Chunyu Li1
1Department of Neurology, Laboratory of Neurodegenerative Disorders, West China Hospital, Sichuan University, Chengdu, China.
Frontiers in Neurology
|July 25, 2022
Summary
This meta-analysis reveals consistent gray matter reductions in the brains of individuals with myotonic dystrophy type 1 (DM1), affecting motor and sensory areas. These brain changes correlate with disease duration and cognitive function.
Area of Science:
- Neuroimaging
- Neurology
- Genetics
Background:
- Myotonic dystrophy type 1 (DM1) is increasingly recognized to affect the brain.
- Previous voxel-based morphometry (VBM) studies show varied gray matter (GM) abnormalities in DM1 patients.
- Consistent GM changes in DM1 require integrated analysis.
Purpose of the Study:
- To perform a meta-analysis of VBM studies to identify consistent GM changes in DM1.
- To correlate regional GM abnormalities with clinical factors.
Main Methods:
- Systematic literature search of Web of Science, Pubmed, and Embase databases.
- Meta-analysis of voxel-based morphometry data using Seed-based d Mapping with Permutation of Subject Images (SDM-PSI) software.
- Meta-regression analysis to explore associations with disease duration and cognitive scores.
Main Results:
- Eight VBM studies were included, comprising 176 DM1 patients and 198 healthy controls.
- Significant reductions in GM volume were observed in DM1 patients across multiple brain regions, including motor, sensory, and associative areas.
- GM abnormalities correlated with disease duration and Rey-Osterrieth Complex Figure (ROCF)-recall scores.
Conclusions:
- Myotonic dystrophy type 1 (DM1) is a multisystem disorder impacting brain regions involved in motor and neuropsychiatric functions.
- Consistent GM reductions provide a basis for understanding the pathophysiology of DM1.
- Brain alterations in DM1 are linked to disease progression and cognitive deficits.

